Stockreport

AIM ImmunoTech Announces Closing of its Rights Offering

AIM ImmunoTech Inc.  (AIM) 
PDF OCALA, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) – AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focus [Read more]